Funding Structure, page-2

I think there is such an apetite for this potential drug that there will be a number of potential partners who would court BIT for a chance at a piece of the action.

The recent announcement did make a point of mentionting possible non-equity comercial partners but not sure about the scope of that. You don't make an application to the FDA without discussions with potential commercial partners already in the pipeline for funding the trial. They wont be wanting to muck around delaying fast tracked trials while they look for funding. This will already be penciled in. IF we get approval they will announce the funding at the same time or very shortly thereafter. It will be all systems go and things will move rapidly.

The share register is not overly bloated so even if there was a share/ rights issue the dillution is not a major factor in my opinion. Cheers